Incorporating clinicopathological and molecular risk prediction tools to improve outcomes in early HR+/HER2– breast cancer

Stratification of recurrence risk is a cornerstone of early breast cancer diagnosis that informs a patient’s optimal treatment pathway. Several tools exist that combine clinicopathological and molecular information, including multigene assays, which can estimate risk of recurrence and quantify the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Curigliano, Giuseppe, Dent, Rebecca, Llombart-Cussac, Antonio, Pegram, Mark, Pusztai, Lajos, Turner, Nicholas, Viale, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307886/
https://www.ncbi.nlm.nih.gov/pubmed/37380659
http://dx.doi.org/10.1038/s41523-023-00560-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307886/
https://www.ncbi.nlm.nih.gov/pubmed/37380659
http://dx.doi.org/10.1038/s41523-023-00560-z

Ejemplares similares